An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA (original) (raw)
New concepts in breast cancer genomics and genetics
Rodrigo Goncalves
Breast Cancer Research, 2014
View PDFchevron_right
A framework for the interpretation of de novo mutation in human disease
Mark Daly
Nature Genetics, 2014
View PDFchevron_right
Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen
John Martens
Oncotarget, 2014
View PDFchevron_right
9q31. 2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
E. Khusnutdinova
2012
View PDFchevron_right
Estradiol and Selective Estrogen Receptor Modulators Differentially Regulate Target Genes with Estrogen Receptors α and β
Aleksandra Cvoro
Molecular Biology of the Cell, 2004
View PDFchevron_right
In vivo transgenic mutation assays
Barry Glickman
Mutation Research, 2003
View PDFchevron_right
Non-canonical Estrogen Signaling in Endocrine Resistance
Prathibha Ranganathan
Frontiers in Endocrinology, 2019
View PDFchevron_right
Genomic assays in breast cancer: Issues yet to settle?
M. Basade
International Journal of Molecular and Immuno Oncology
View PDFchevron_right
Physiological and Pathological Roles of Estrogen Receptor
Kenneth Korach
Estrogen Receptor and Breast Cancer, 2018
View PDFchevron_right
Point Mutation in the Ligand-Binding Domain of the Progesterone Receptor Generates a Transdominant Negative Phenotype
sebastian chavez
Molecular Endocrinology, 1997
View PDFchevron_right
Tissue-Specific Estrogens — The Promise for the Future
Ghada Fuleihan
New England Journal of Medicine, 1997
View PDFchevron_right
Sex-reversed phenotype in association with two novel mutations c.2494delA and c.T3004C in the ligand-binding domain of the androgen receptor gene
Angeliki Galani
Fertility and Sterility, 2008
View PDFchevron_right
Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations
Charles Sultan
Molecular and Cellular Endocrinology, 1996
View PDFchevron_right
Frequency of TERT promoter mutations in human cancers
Ana Preto
Nature Communications, 2013
View PDFchevron_right
Comparison of in Vivo and in Vitro Reporter Gene Assays for Short-Term Screening of Estrogenic Activity
Andre Vethaak
Environmental Science & Technology, 2002
View PDFchevron_right
Unbalanced estrogen metabolism in ovarian cancer
Cheryl Beseler
International Journal of Cancer, 2014
View PDFchevron_right
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Geraldine Laven-Law
Nature Medicine, 2021
View PDFchevron_right
The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor α
Kazunori Nagasaka
British Journal of Cancer, 2005
View PDFchevron_right
Effect Sizes of Somatic Mutations in Cancer
Jeffrey Townsend
JNCI: Journal of the National Cancer Institute, 2018
View PDFchevron_right
High Throughput Parallel Analysis of Hundreds of Patient Samples for More Than 100 Mutations in Multiple Disease Genes
Katherine Klinger
Human Molecular Genetics, 1997
View PDFchevron_right
Short report: MonitoringESR1mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer
Cristian Petre Moldovan
International Journal of Cancer, 2015
View PDFchevron_right
Estrogens and development
john mclachlan
Environmental Health Perspectives, 1987
View PDFchevron_right
Discovering moderate-risk breast cancer susceptibility genes
John Martens
Current Opinion in Genetics & Development, 2010
View PDFchevron_right
Elucidating the role of androgen receptor in breast cancer
Aditi H
Clinical Investigation, 2012
View PDFchevron_right
Identification of cancer genes by mutational profiling of tumor genomes
Sabrina Arena
FEBS Letters, 2005
View PDFchevron_right